CLINICAL TRIALS PROFILE FOR CARBACHOL
✉ Email this page to a colleague
All Clinical Trials for CARBACHOL
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00357864 ↗ | Carbachol´s Headache Inducing Characteristics and Effects on the Cerebral Blood Flow | Completed | Danish Headache Center | 2006-07-01 | To investigate headache score and accompanying symptoms during and after infusion of carbachol. | |
| NCT00564408 ↗ | Carbachols Headache-inducing Effect and Changes in Cerebral Blood Flow in Migraine Patients | Completed | Danish Headache Center | N/A | 2007-08-01 | The purpose of this study is to test if carbachol infusion induces headache in migraine subjects as well as intra- and extra-cerebral vasodilatation. |
| NCT00861211 ↗ | Safety and Efficacy Study of Oral Senicapoc on Allergen Challenge in Atopic Asthmatic Subjects | Completed | Icagen | Phase 2 | 2008-10-01 | The purpose of the study is to determine whether senicapoc can decrease changes in FEV1 following allergen challenge in atopic allergic subjects. |
| NCT02807415 ↗ | ICM to Evaluate the Activation of p.Phe508del-CFTR by Lumacaftor in Combination With Ivacaftor | Completed | Heidelberg University | 2016-06-01 | The academic investigator - initiated trial will evaluate in a postapproval setting whether, and if yes, to what extent and variability, the treatment with lumacaftor in combination with ivacaftor reverses the p.Phe508del CFTR - mediated basic defect in p.Phe508del homozygous subjects with cystic fibrosis under real life conditions. | |
| NCT02807415 ↗ | ICM to Evaluate the Activation of p.Phe508del-CFTR by Lumacaftor in Combination With Ivacaftor | Completed | University of Giessen | 2016-06-01 | The academic investigator - initiated trial will evaluate in a postapproval setting whether, and if yes, to what extent and variability, the treatment with lumacaftor in combination with ivacaftor reverses the p.Phe508del CFTR - mediated basic defect in p.Phe508del homozygous subjects with cystic fibrosis under real life conditions. | |
| NCT02807415 ↗ | ICM to Evaluate the Activation of p.Phe508del-CFTR by Lumacaftor in Combination With Ivacaftor | Completed | Hannover Medical School | 2016-06-01 | The academic investigator - initiated trial will evaluate in a postapproval setting whether, and if yes, to what extent and variability, the treatment with lumacaftor in combination with ivacaftor reverses the p.Phe508del CFTR - mediated basic defect in p.Phe508del homozygous subjects with cystic fibrosis under real life conditions. | |
| NCT04774237 ↗ | Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia | Completed | Visus Therapeutics | Phase 2 | 2021-03-24 | Safety and Efficacy Study of BRIMOCHOL™ vs. BRIMOCHOL™ F vs. Carbachol Monotherapy Topical Ophthalmic Solutions in Subjects with Emmetropic Phakic and Pseudophakic Presbyopia |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CARBACHOL
Condition Name
Clinical Trial Locations for CARBACHOL
Trials by Country
Clinical Trial Progress for CARBACHOL
Clinical Trial Phase
Clinical Trial Sponsors for CARBACHOL
Sponsor Name
